RATIONALE: Physicians self-report high adherence rates for Ask and Advise behaviors of tobacco dependence treatment but are much less likely to engage in "next steps" consistent with sophisticated management of chronic illness. A variety of potential explanations have been offered, yet each lacks face validity in light of experience with other challenging medical conditions. OBJECTIVE: Conduct a preliminary exploration of the behavioral economics of tobacco treatment decision-making in the face of uncertain outcomes, seeking evidence that behaviors may be explained within the framework of Prospect Theory. METHODS: Four physician cohorts were polled regarding their impressions of the utility of tobacco use treatment and their estimations of "success" probabilities. Contingent valuation was estimated by asking respondents to make monetary tradeoffs relative to three common chronic conditions. MEASUREMENTS AND MAIN RESULTS: Responses from all four cohorts showed a similar pattern of high utility of tobacco use treatment but low success probability when compared with the other chronic medical conditions. Following instructional methods aimed at controverting cognitive biases related to tobacco, this pattern was reversed, with success probabilities attaining higher valuation than for diabetes. CONCLUSIONS: Important presuppositions regarding the potential "success" of tobacco-related patient interactions are likely limiting physician engagement by favoring the most secure visit outcome despite the limited potential for health gains. Under these conditions, low engagement rates would be consistent with Prospect Theory predictions. Interventions aimed at counteracting the cognitive biases limiting estimations of success probabilities seem to effectively reverse this pattern and provide clues to improving the adoption of target clinical behaviors.
RATIONALE: Physicians self-report high adherence rates for Ask and Advise behaviors of tobacco dependence treatment but are much less likely to engage in "next steps" consistent with sophisticated management of chronic illness. A variety of potential explanations have been offered, yet each lacks face validity in light of experience with other challenging medical conditions. OBJECTIVE: Conduct a preliminary exploration of the behavioral economics of tobacco treatment decision-making in the face of uncertain outcomes, seeking evidence that behaviors may be explained within the framework of Prospect Theory. METHODS: Four physician cohorts were polled regarding their impressions of the utility of tobacco use treatment and their estimations of "success" probabilities. Contingent valuation was estimated by asking respondents to make monetary tradeoffs relative to three common chronic conditions. MEASUREMENTS AND MAIN RESULTS: Responses from all four cohorts showed a similar pattern of high utility of tobacco use treatment but low success probability when compared with the other chronic medical conditions. Following instructional methods aimed at controverting cognitive biases related to tobacco, this pattern was reversed, with success probabilities attaining higher valuation than for diabetes. CONCLUSIONS: Important presuppositions regarding the potential "success" of tobacco-related patient interactions are likely limiting physician engagement by favoring the most secure visit outcome despite the limited potential for health gains. Under these conditions, low engagement rates would be consistent with Prospect Theory predictions. Interventions aimed at counteracting the cognitive biases limiting estimations of success probabilities seem to effectively reverse this pattern and provide clues to improving the adoption of target clinical behaviors.
Authors: Lawrence C An; Terence S Bernhardt; James Bluhm; Patricia Bland; Bruce Center; Jasjit S Ahluwalia; Steven S Foldes; Sanne Magnan; Marc Manley Journal: Prev Med Date: 2004-05 Impact factor: 4.018
Authors: M A O'Brien; S Rogers; G Jamtvedt; A D Oxman; J Odgaard-Jensen; D T Kristoffersen; L Forsetlund; D Bainbridge; N Freemantle; D A Davis; R B Haynes; E L Harvey Journal: Cochrane Database Syst Rev Date: 2007-10-17
Authors: Frank T Leone; Kai-Håkon Carlsen; David Chooljian; Laura E Crotty Alexander; Frank C Detterbeck; Michelle N Eakin; Sarah Evers-Casey; Harold J Farber; Patricia Folan; Hasmeena Kathuria; Karen Latzka; Shane McDermott; Sharon McGrath-Morrow; Farzad Moazed; Alfred Munzer; Enid Neptune; Smita Pakhale; David P L Sachs; Jonathan Samet; Beth Sufian; Dona Upson Journal: Am J Respir Crit Care Med Date: 2018-10-15 Impact factor: 21.405
Authors: Dalia Littman; Scott E Sherman; Andrea B Troxel; Elizabeth R Stevens Journal: Int J Environ Res Public Health Date: 2022-07-04 Impact factor: 4.614
Authors: Frank T Leone; Yuqing Zhang; Sarah Evers-Casey; A Eden Evins; Michelle N Eakin; Joelle Fathi; Kathleen Fennig; Patricia Folan; Panagis Galiatsatos; Hyma Gogineni; Stephen Kantrow; Hasmeena Kathuria; Thomas Lamphere; Enid Neptune; Manuel C Pacheco; Smita Pakhale; David Prezant; David P L Sachs; Benjamin Toll; Dona Upson; Dan Xiao; Luciane Cruz-Lopes; Izabela Fulone; Rachael L Murray; Kelly K O'Brien; Sureka Pavalagantharajah; Stephanie Ross; Yuan Zhang; Meng Zhu; Harold J Farber Journal: Am J Respir Crit Care Med Date: 2020-07-15 Impact factor: 21.405
Authors: Brian P Jenssen; Robert Schnoll; Rinad Beidas; Justin Bekelman; Anna-Marika Bauer; Callie Scott; Sarah Evers-Casey; Jody Nicoloso; Peter Gabriel; David A Asch; Alison Buttenheim; Jessica Chen; Julissa Melo; Lawrence N Shulman; Alicia B W Clifton; Adina Lieberman; Tasnim Salam; Kelly Zentgraf; Katharine A Rendle; Krisda Chaiyachati; Rachel Shelton; E Paul Wileyto; Sue Ware; Frank Leone Journal: Implement Sci Date: 2021-07-15 Impact factor: 7.327